Name: Latest research reports of Marksans Pharma Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Marksans Pharma Ltd.
Rating: 5
Author: Axis Direct

Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

326.7500 -5.45 (-1.64%)

NSE Sep 04, 2026 15:31 PM

110.81% Gain from 52W Low

Volume: 1.7M

Marksans Pharma Ltd.

31 Aug 2026

326.75

-1.64%

Axis Punch:Marksans Pharma

Buy: Marksans Pharma Ltd.

Axis Direct

We recommend a BUY on the stock with a target price of Rs 362/share, implying an upside of 10% from the CMP.

Marksans Pharma has gained 40.12% in the last 3 Months